Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Blood|November 10, 2010
MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemiaFay J Hosking, Stephen Leslie, Alexander Dilthey, et al.Journal of Medicinal Chemistry|September 12, 2022
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid LeukemiaJosé Luis Marín-Rubio, Rachel E Peltier-Heap, Maria Emilia Dueñas, et al.Journal of the National Cancer Institute|February 2, 2006
Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patientsSara J Schonfeld, Ethel S Gilbert, Graça M Dores, et al.British Journal of Haematology|November 9, 2022
Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasmsAndrew J Shih, Tomi Jun, Andrew D Skol, et al.Blood Advances|May 24, 2018
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductaseSarah E Fordham, Helen J Blair, Claire J Elstob, et al.Nature Communications|August 11, 2019
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomicsHelen E Speedy, Renée Beekman, Vicente Chapaprieta, et al.Blood|July 30, 2005
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factorsDeirdre A Hill, Ethel Gilbert, Graça M Dores, et al.Cell Reports|August 16, 2016
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer PolymorphismRadhika Kandaswamy, Georgina P Sava, Helen E Speedy, et al.Cell Reports. Medicine|August 17, 2022
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemiaDeepali Pal, Helen Blair, Jessica Parker, et al.Journal of the National Cancer Institute|June 30, 2010
Testicular cancer survivorship: research strategies and recommendationsLois B Travis, Clair Beard, James M Allan, et al.Pageof 8